logo

For the Inventor, By the Inventor

Dion-Valmont, Belgium

Joseph L Roba

USPTO Granted Patents = 13

 

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 159(Granted Patents)


Location History:

  • Ciernont-Houyet, BE (1981)
  • Dion-Le-Val, BE (1982)
  • Ciergnon-Houyet, BE (1984)
  • Wanlin, BE (1976 - 1987)
  • Houyet, BE (1987)
  • Dion-Valmont, BE (1985 - 1995)

Company Filing History:

goldMedal8 out of 11 
 
Continental Pharma Incorporated
 patents
silverMedal3 out of 1,323 
 
G.d. Searle & Company
 patents
bronzeMedal1 out of 1 
 
Continental Pharma S.a.
 patent
4. 1 out of 1 
 
Midit, Societe Fiduciaire
 patent

Years Active: 1976-1995

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 5462965 - Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases (1995-10-31),
2. 4853401 - Spiro-hydantoins as aldose reductase inhibitors (1989-08-01),
3. 4738979 - .alpha..sub.2 -blocking derivatives of imidazole (1988-04-19),
4. 4639468 - Derivatives of glycinamide, their preparation and their use (1987-01-27),
5. 4638070 - Heterocyclic amino-alcohol derivatives (1987-01-20),
6. 4562205 - Derivatives of 2-aminoacetic acid (1985-12-31),
7. 4507314 - Drug for treating affections provoked by a too high histamine level, of (1985-03-26),
8. 4474977 - Amino-alcohol derivatives (1984-10-02),
9. 4338330 - Benzimidazole derivatives, their use, and compositions containing these (1982-07-06),
10. 4285964 - Salts of (+)-catechine, their preparation and use, and compositions (1981-08-25),
11. 4268517 - Pharmaceutical composition and therapeutical method for treating (1981-05-19),
12. 4228187 - Alkyl and cycloalkylthiophenylalkylaminoalkanols, their salts and the (1980-10-14),
13. 3954871 - 1-(4-Alkylthiopheny)-2-substituted amino-alcohols and their salts (1976-05-04),

Title: Joseph L Roba: Innovator in CNS Disease Treatment

Introduction

Joseph L Roba is a notable inventor based in Dion-Valmont, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) diseases. With a total of 13 patents to his name, Roba's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Roba has developed innovative compounds such as heterocyclic amino-alcohols for the treatment of CNS diseases. Additionally, he has worked on spiro-hydantoins as aldose reductase inhibitors. This invention relates to spirohydantoins of the formula I, where R₁ and R₂ are defined in the patent documentation. The patents also disclose methods of preparation, pharmaceutical compositions containing these compounds, and their applications in treating and preventing complications of diabetes and galactosemia.

Career Highlights

Throughout his career, Joseph L Roba has been associated with several prominent companies, including Continental Pharma Incorporated and G.D. Searle & Company. His work in these organizations has allowed him to advance his research and contribute to the development of new therapeutic solutions.

Collaborations

Roba has collaborated with notable professionals in his field, including Georges E Lambelin and Claude L Gillet. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical research.

Conclusion

Joseph L Roba's contributions to the field of CNS disease treatment through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…